Navigation thread
Navigation thread
Age-related Macular Degeneration (AMD)
Make a donation
Make a donation
Joint project with . This link opens in a new tab.

Treatment of AMD at the Clínic

Reading time: 1 min

The Hospital Clínic Barcelona is a benchmark in the use of the most innovative treatments for Age-Related Macular Degeneration (AMD).

Wet AMD (neovascular) is a retina ageing process to which is added abnormal growth of blood vessels behind the macula, leading to image distortion. It is managed with periodic intraocular injections (intravitreal therapy) that slow the progression of the disease. 

Intravitreal therapy has transformed the visual prognosis for the disease, as it stabilises vision and, in some cases, improves it. This type of treatment is personalised and requires strict adherence. 

At the Ophthalmology Clínic Institute (Institut Clínic de Oftalmologia, ICOF), found between the Maternity and Sagrat Cor sites, over 10,000 intravitreal therapies are performed each year for the treatment of retinal diseases, most of which are for AMD. 

Read more Research at the Clinic
Joint project with . This link opens in a new tab.

Substantiated information by:

Javier Zarranz Ventura
Mª Socorro Alforja Castiella
Ricardo P Casaroli Marano

Published: 20 February 2018
Updated: 11 July 2025

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.

Age-related Macular Degeneration (AMD) related news